CRDO

The Next Nvidia? If Energy Is The Bottleneck, Efficiency Can Be The Solution

The Cable Guy AI Couldn't Live Without: Why Credo Technology Matters Right Now

When NVIDIA gets all the glory for powering artificial intelligence, there's a quiet company making sure those fancy GPUs can actually talk to each other. Meet Credo Technology, the connectivity specialist that's become the plumbing contractor to the AI mansion—and business is absolutely booming.

What Does Credo Actually Do?

Credo Technology provides the high-speed wiring that connects everything inside AI data centers. Their flagship product, Active Electrical Cables (AECs), has become the de facto standard for hyperscale AI clusters. Think of it this way: if GPUs are the brains of AI, Credo builds the nervous system.

The company's AECs deliver 100 times better reliability than traditional optical solutions while consuming half the power. When hyperscalers like Amazon, Microsoft, and Google are building clusters with hundreds of thousands of GPUs, they cannot afford cables that flicker or fail. Credo's "ZeroFlap" technology guarantees stable connections, and that reliability has made their products mission-critical.

Beyond cables, Credo sells optical Digital Signal Processors, PCIe retimers, and licenses its proprietary SerDes intellectual property. This diversification is accelerating, with optical revenue expected to double in fiscal 2026.

The Numbers Are Staggering

Credo's most recent quarter was historic. Revenue hit $268 million, up 272% year-over-year and 20% sequentially. Non-GAAP gross margin landed at 67.7%, while net margin reached an extraordinary 47.7%. For context, that profitability rivals the best software companies, yet Credo sells physical hardware.

Even more impressive, management guided Q3 revenue to $335-345 million, representing 159% year-over-year growth—dramatically beating Wall Street's expectations of $247 million. Full fiscal year 2026 should deliver more than 170% revenue growth. The company has beaten earnings estimates for four consecutive quarters, with the most recent quarter showing EPS of $0.67 versus expectations of $0.49.

Moat Analysis: Deeper Than It Appears

Credo's competitive advantage stems from its system-level approach. The company owns the entire stack: SerDes IP, retimer integrated circuits, and end-to-end system design. This integration allows faster innovation cycles and superior cost efficiency.

The proprietary "N-1" SerDes architecture enables Credo to manufacture chips on the previous-generation process node while matching or exceeding competitors' performance on cutting-edge nodes. This translates to structurally lower manufacturing costs and better yields.

Customer switching costs are substantial. Once a hyperscaler qualifies Credo's AECs into their server platform architecture, ripping them out becomes extraordinarily expensive and risky. AI clusters cannot tolerate downtime for cable swaps.

Competition exists from Broadcom, Marvell, and upstart Astera Labs, but Credo's first-mover advantage in AECs and proven reliability at scale has created significant barriers.

🟨 The Yellowbrick RoadGet the best stock ideas from billion-dollar hedge funds, professional analysts, millionaire traders, and more in a free, daily email.

Balance Sheet: Fortress Mode

Credo ended Q2 with $813.6 million in cash and essentially zero debt. The debt-to-equity ratio sits at 0.02, and the current ratio stands at 7.4. This provides more than two years of operating expenses even in a worst-case scenario.

The company generates substantial free cash flow—$38.5 million last quarter despite elevated capital expenditures for 3nm mask sets. This financial firepower enables continued R&D investment without shareholder dilution, though management did complete an ATM offering in October to build additional strategic flexibility.

Profitability Trajectory: Software Economics in Hardware

The margin expansion story is compelling. Non-GAAP operating expenses grew just 50% while revenue nearly quadrupled. Operating leverage is extraordinary—each incremental dollar of revenue drops significant profit to the bottom line.

Net margins have expanded from barely profitable to 47.7% in the most recent quarter. Management expects margins to moderate slightly as product mix shifts and R&D investments increase, but the underlying profitability engine appears durable.

Reinvestment and Capital Allocation

Credo plows virtually all profits back into growth. R&D spending focuses on next-generation products: 3nm optical DSPs for 1.6 terabit per second connections, PCIe retimers for Gen 6, and the recently acquired Hyperlume micro-LED technology for chip-to-chip optical interconnects.

The company has no dividend and does no buybacks—appropriate for a hypergrowth phase. Capital allocation discipline appears sound, with management funding growth organically rather than diluting shareholders excessively.

The Concentration Risk

Three hyperscalers each contribute more than 10% of revenue, with the largest representing approximately 35%. A fourth customer is ramping toward the 10% threshold. Customer concentration is improving but remains the primary business risk.

Hyperscaler capital expenditure cycles are notoriously volatile. If AI infrastructure spending pauses—even temporarily—Credo's revenue would suffer disproportionately. The flip side: as long as AI training and inference demand accelerates, Credo rides the wave.

Valuation Reality Check

At $150.13 per share, Credo commands a market capitalization approaching $29 billion. On trailing twelve months revenue, that represents roughly 20x sales. Forward price-to-earnings sits around 56-70x depending on which fiscal year estimates you use.

Running a reverse DCF suggests the market prices in approximately 40-50% annual revenue growth for the next five years, followed by 20% growth thereafter, with terminal margins near 35%. Those assumptions are aggressive but not unrealistic given current trajectory.

The stock hit an all-time high of $213 in early December before pulling back nearly 30%. Volatility is extreme—the 52-week range spans $29 to $214.

Overall CRDO Score: 76/100

  1. Essential vs. Nice-to-Have: 8/10 — Mission-critical for AI infrastructure, though cyclical

  2. Current Moats: 7/10 — Strong but competitors exist; customer switching costs help

  3. Moats Expanding: 8/10 — New products, diversifying customers, deeper hyperscaler integration

  4. Balance Sheet Strength: 10/10 — $814M cash, zero debt, current ratio 7.4

  5. EPS Acceleration: 10/10 — From $0.07 to $0.67 YoY; triple-digit growth

  6. Net Margins Increasing: 9/10 — Expanded to 47.7%; slight moderation expected

  7. ROIC Profile: 8/10 — Fabless model delivers excellent returns; still scaling

  8. Reinvestment Rate: 9/10 — Heavy R&D investment; organic growth funding

  9. Capital Return: 3/10 — No dividends or buybacks; appropriate for growth phase

  10. Valuation: 4/10 — 20x sales, 56-70x forward P/E; prices in significant growth

Credo Technology represents a rare combination: explosive growth, exceptional profitability, pristine balance sheet, and genuine competitive moats. The company has successfully navigated from development-stage IP licensing to becoming an essential infrastructure supplier for the AI buildout.

The valuation demands near-perfect execution. Customer concentration adds fragility. Yet the underlying business quality is undeniable, and the secular tailwinds remain powerful. The business quality is undeniable. The valuation requires conviction. Right now it sits on my watchlist, which you can access in real-time in our community.

Would you like to stay ahead of opportunities like this? Join our community where we share real-time trade alerts and deep-dive analyses of businesses with true competitive advantages. Don't just trade the market - invest in excellence.

Want to receive our trade alerts and detailed analysis in real-time? Join our community of value investors who understand that pricing power is the ultimate competitive advantage. Receive our trade alerts on your phone? Download the app here 

Pari PassuRestructuring, Public and Private Investing, and Niche Finance Topics Note from Private Equity Investor at Mega-Fund